Literature DB >> 24106873

Why is melanoma so metastatic?

Russell R Braeuer1, Ian R Watson, Chang-Jiun Wu, Aaron K Mobley, Takafumi Kamiya, Einav Shoshan, Menashe Bar-Eli.   

Abstract

Malignant melanoma is one of the most aggressive cancers and can disseminate from a relatively small primary tumor and metastasize to multiple sites, including the lung, liver, brain, bone, and lymph nodes. Elucidating the molecular and genetic changes that take place during the metastatic process has led to a better understanding of why melanoma is so metastatic. Herein, we describe the unique features that distinguish melanoma from other solid tumors and contribute to the malignant phenotype of melanoma cells. For example, although melanoma cells are highly antigenic, they are extremely efficient at evading host immune response. Melanoma cells share numerous cell surface molecules with vascular cells, are highly angiogenic, are mesenchymal in nature, and possess a higher degree of 'stemness' than do other solid tumors. Finally, analysis of melanoma mutations has revealed that the gene expression profile of malignant melanoma is different from that of other cancers. Elucidating these molecular and genetic processes in highly metastatic melanoma can lead to the development of improved treatment and individualized therapy options.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  angiogenesis; mesenchymal phenotype; metastasis; mutations profile; stemness

Mesh:

Substances:

Year:  2013        PMID: 24106873     DOI: 10.1111/pcmr.12172

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN: 1755-1471            Impact factor:   4.693


  40 in total

1.  Compound 13, an α1-selective small molecule activator of AMPK, potently inhibits melanoma cell proliferation.

Authors:  Xueqing Hu; Fangzhen Jiang; Qi Bao; Huan Qian; Quan Fang; Zheren Shao
Journal:  Tumour Biol       Date:  2015-08-14

2.  Toward predicting metastatic progression of melanoma based on gene expression data.

Authors:  Yuanyuan Li; Juno M Krahn; Gordon P Flake; David M Umbach; Leping Li
Journal:  Pigment Cell Melanoma Res       Date:  2015-04-24       Impact factor: 4.693

3.  From Proteomic Mapping to Invasion-Metastasis-Cascade Systemic Biomarkering and Targeted Drugging of Mutant BRAF-Dependent Human Cutaneous Melanomagenesis.

Authors:  Aikaterini F Giannopoulou; Athanassios D Velentzas; Athanasios K Anagnostopoulos; Adamantia Agalou; Nikos C Papandreou; Stamatia A Katarachia; Dimitra G Koumoundourou; Eumorphia G Konstantakou; Vasiliki I Pantazopoulou; Anastasios Delis; Maria T Michailidi; Dimitrios Valakos; Dimitris Chatzopoulos; Popi Syntichaki; Vassiliki A Iconomidou; Ourania E Tsitsilonis; Issidora S Papassideri; Gerassimos E Voutsinas; Polydefkis Hatzopoulos; Dimitris Thanos; Dimitris Beis; Ema Anastasiadou; George Th Tsangaris; Dimitrios J Stravopodis
Journal:  Cancers (Basel)       Date:  2021-04-22       Impact factor: 6.639

Review 4.  Pro-survival role of MITF in melanoma.

Authors:  Mariusz L Hartman; Malgorzata Czyz
Journal:  J Invest Dermatol       Date:  2014-08-21       Impact factor: 8.551

5.  Pharmacological activation of estrogen receptor beta augments innate immunity to suppress cancer metastasis.

Authors:  Linjie Zhao; Shuang Huang; Shenglin Mei; Zhengnan Yang; Lian Xu; Nianxin Zhou; Qilian Yang; Qiuhong Shen; Wei Wang; Xiaobing Le; Wayne Bond Lau; Bonnie Lau; Xin Wang; Tao Yi; Xia Zhao; Yuquan Wei; Margaret Warner; Jan-Åke Gustafsson; Shengtao Zhou
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-28       Impact factor: 11.205

6.  OSW-1 induces apoptosis and cyto-protective autophagy, and synergizes with chemotherapy on triple negative breast cancer metastasis.

Authors:  Mengling Wu; Qianrui Huang; Mengya Liao; Xuyi Wu; Huizhi Xi; Hongbo Ma; Shanrui Li; Yiwen Zhang; Yong Xia
Journal:  Cell Oncol (Dordr)       Date:  2022-09-26       Impact factor: 7.051

7.  Sequential molecular analysis of circulating MCAM/MUC18 expression: a promising disease biomarker related to clinical outcome in melanoma.

Authors:  Maria Cristina Rapanotti; Tara Mayte Suarez Viguria; Gaetana Costanza; Ilaria Ricozzi; Andrea Pierantozzi; Alessandro Di Stefani; Elena Campione; Sergio Bernardini; Sergio Chimenti; Augusto Orlandi; Luca Bianchi
Journal:  Arch Dermatol Res       Date:  2014-06-07       Impact factor: 3.017

8.  Enhancer methylation dynamics contribute to cancer plasticity and patient mortality.

Authors:  Rachel E Bell; Tamar Golan; Danna Sheinboim; Hagar Malcov; David Amar; Avi Salamon; Tamar Liron; Sahar Gelfman; Yankel Gabet; Ron Shamir; Carmit Levy
Journal:  Genome Res       Date:  2016-02-23       Impact factor: 9.043

9.  Phorbol ester-induced neutrophilic inflammatory responses selectively promote metastatic spread of melanoma in a TLR4-dependent manner.

Authors:  Tobias Bald; Jennifer Landsberg; Philipp Jansen; Evelyn Gaffal; Thomas Tüting
Journal:  Oncoimmunology       Date:  2015-09-01       Impact factor: 8.110

10.  Tumor microenvironment immune-related lncRNA signature for patients with melanoma.

Authors:  Jia-Hui Guo; Shan-Shan Yin; Hua Liu; Feng Liu; Feng-Hou Gao
Journal:  Ann Transl Med       Date:  2021-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.